Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $0.51 on revenue of $1.14B. Analysts polled by Investing.com forecast EPS of $0.44 on revenue of $1.08B. .
For the year, Edwards Lifesciences shares are up 7.52%, outperforming the S&P 500 which is up 6.31% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, October 13, 2020, J&J reported third quarter EPS of $2.2 on revenue of $21.08B, compared to forecasts of EPS of $1.98 on revenue of $20.2B.
Abbott Labs earnings beat analyst's expectations on Wednesday, with third quarter EPS of $0.98 on revenue of $8.85B. Investing.com analysts expected EPS of $0.9 on revenue of $8.5B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar